Eledon Pharmaceuticals
ELDN
ELDN
75 hedge funds and large institutions have $159M invested in Eledon Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
127% more funds holding
Funds holding: 33 → 75 (+42)
17.82% more ownership
Funds ownership: 46.61% → 64.43% (+18%)
Holders
75
Holding in Top 10
1
Calls
$74K
Puts
$11K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$9.59M | |
| 3 | +$8.07M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.48M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.17M |
Top Sellers
| 1 | -$5.89M | |
| 2 | -$2.82M | |
| 3 | -$46.1K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$27.5K |
| 5 |
JPMorgan Chase & Co
New York
|
-$242 |